Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices

E Gultepe, D Nagesha, S Sridhar, M Amiji - Advanced drug delivery reviews, 2010 - Elsevier
The characteristics of nanoporous inorganic coatings on implants or on implantable devices
are reviewed. The commonly used nanoporous materials, such as aluminum oxide (Al2O3) …

Endogenous opiates and behavior: 2005

RJ Bodnar, GE Klein - Peptides, 2006 - Elsevier
This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …

Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009

RP Schwartz, J Gryczynski… - … journal of public …, 2013 - ajph.aphapublications.org
Objectives. We examined the association between the expansion of methadone and
buprenorphine treatment and the prevalence of heroin overdose deaths in Baltimore …

[图书][B] Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence

World Health Organization. Department of Mental … - 2009 - books.google.com
These Guidelinesreview the use of medicines such as methadone, buprenorphine,
naltrexone and clonidine in combination with psychosocial support in the treatment of …

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity …

AR Lingford-Hughes, S Welch… - Journal of …, 2012 - journals.sagepub.com
The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

SD Comer, MA Sullivan, E Yu… - Archives of general …, 2006 - jamanetwork.com
Context Oral naltrexone can completely antagonize the effects produced by opioid agonists.
However, poor compliance with naltrexone has been a major obstacle to the effective …

Evidence-based treatment of opioid-dependent patients

W Van den Brink, C Haasen - The Canadian Journal of …, 2006 - journals.sagepub.com
Objective: To provide an overview of treatment options for opioid-dependent patients.
Method: We screened all published studies on the treatment of opioid dependence, with a …

The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data

WO Farid, SA Dunlop, RJ Tait… - Current …, 2008 - ingentaconnect.com
Most women using heroin are of reproductive age with major risks for their infants. We
review clinical and experimental data on fetal, neonatal and postnatal complications …

Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice

SC Sigmon, A Bisaga, EV Nunes… - The American journal …, 2012 - Taylor & Francis
Background: Opioid dependence is a significant public health problem associated with high
risk for relapse if treatment is not ongoing. While maintenance on opioid agonists (ie …

[HTML][HTML] Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former …

AD Fox, J Maradiaga, L Weiss, J Sanchez… - Addiction science & …, 2015 - Springer
Abstract Background The United States has the highest rate of incarceration in the world
(937 per 100,000 adults). Approximately one-third of heroin users pass through correctional …